Jimenez, E., Astbury, C., Albayaty, M., Wählby-Hamrén, U., Seoane, B., Villarroel, C., . . . Psallidas, I. (2020). Navafenterol (AZD8871) in patients with mild asthma: A randomised placebo-controlled phase I study evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of single ascending doses of this novel inhaled long-acting dual-pharmacology bronchodilator. Respir Res.
Chicago Style citaatJimenez, Eulalia, et al. "Navafenterol (AZD8871) in Patients With Mild Asthma: A Randomised Placebo-controlled Phase I Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of This Novel Inhaled Long-acting Dual-pharmacology Bronchodilator." Respir Res 2020.
MLA citatieJimenez, Eulalia, et al. "Navafenterol (AZD8871) in Patients With Mild Asthma: A Randomised Placebo-controlled Phase I Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of This Novel Inhaled Long-acting Dual-pharmacology Bronchodilator." Respir Res 2020.